Psychedelics have gained a long history of stigmatization from both political and sociological outcries as being an addictive drug with potentially dangerous, or even deadly, side effects. This is generally considered the most crucial reason for the drastic decrease in, if not altogether halting, the research of the benefits or possible methods and applications of psychedelics in the treatment of mental disorders. Despite this long and bleak history, with the recent passing of legislation to ease restrictions, largely due to a slow yet meticulous research that is once again shedding light on the efficacy of psychedelics at treating mental health disorders, such as PTSD, anxiety, and depression. Psychedelics are once again gaining a more positive force in the mental health community and the public writ large. Current research, like those studies that aided in lifting of government restrictions, is starting to gain enough of a basis to allow for the comparing of the effectiveness of psychedelics to traditional drug treatment for mental health.